Oct 07, 2015 7:00am EDT Can-Fite to Deliver 2 Presentations on its Cancer Drug CF102 at the 20th World Congress on Advances in Oncology and 18th International Symposium on Molecular Medicine on October 8-10, 2015 in Athens
Sep 29, 2015 10:11am EDT Can-Fite to Present CF101 Psoriasis Data at Late Breaking Session of the EADV Congress in Copenhagen on October 10, 2015
Sep 17, 2015 7:00am EDT U.S. Food and Drug Administration Grants Fast Track Designation to Can-Fite's CF102 in the Treatment of Liver Cancer
Sep 01, 2015 7:00am EDT Can-Fite to Present at Rodman & Renshaw 17th Annual Global Investment Conference on September 9, 2015
Jul 29, 2015 7:00am EDT World Health Organization Accepted "Piclidenoson" as Proposed New Generic Name for Can-Fite's Lead Drug Candidate CF101
Jul 23, 2015 7:00am EDT Can-Fite Joins Israeli Life Sciences Delegation to Japan on July 28 - 30, 2015
Jun 29, 2015 7:00am EDT Can-Fite's CF602 Sexual Dysfunction Drug Backed by New Preclinical Data Progresses Towards an IND
